Cd4 Based Vaccines - Infectious Diseases

Relevant Publications

Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization.

Issue Release: 2024

HLAIImaster: a deep learning method with adaptive domain knowledge predicts HLA II neoepitope immunogenic responses.

Issue Release: 2024

Silicon or Calcium Doping Coordinates the Immunostimulatory Effects of Aluminum Oxyhydroxide Nanoadjuvants in Prophylactic Vaccines.

Issue Release: 2024

Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins.

Issue Release: 2024

Immune Response after Anti-SARS-CoV-2 mRNA Vaccination in Relation to Cellular Immunity, Vitamin D and Comorbidities in Hemodialysis Patients.

Issue Release: 2024

Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.

Issue Release: 2024

LNP-mRNA vaccine prevents type 1 diabetes in non-obese diabetes mice.

Issue Release: 2024

Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac.

Issue Release: 2024

Next generation yellow fever vaccine induces an equivalent immune and transcriptomic profile to the current vaccine: observations from a phase I randomised clinical trial.

Issue Release: 2024

Differentiation marker-negative CD4 T cells persist after yellow fever virus vaccination and contribute to durable memory.

Issue Release: 2024

Ag85B-ENO1 therapeutic vaccines enhance anti-tumor immunity by inducing CD8 T cells and remodeling tumor microenvironment.

Issue Release: 2024

Blended BA.5 infection within 8 days after a boosted bivalent mRNA vaccination strengthens and lengthens the host immunity.

Issue Release: 2024

Flublok Quadrivalent Vaccine Adjuvanted with R-DOTAP Elicits a Robust and Multifunctional CD4 T Cell Response That Is of Greater Magnitude and Functional Diversity Than Conventional Adjuvant Systems.

Issue Release: 2024

Immunogenicity and efficacy of XBB.1.5 rS vaccine against EG.5.1 variant of SARS-CoV-2 in Syrian hamsters.

Issue Release: 2024

Investigation of the safety and protective efficacy of an attenuated and marker -BoHV-1 combined vaccine in bovines.

Issue Release: 2024

Investigation of the safety and protective efficacy of an attenuated and marker -BoHV-1 combined vaccine in bovines.

Issue Release: 2024

Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model.

Issue Release: 2024

An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity.

Issue Release: 2024

Immuno-informatics study identifies conserved T cell epitopes in non-structural proteins of Bluetongue virus serotypes: formulation of a computationally optimized next-generation broad-spectrum multi-epitope vaccine.

Issue Release: 2024

Poly(allylamine)-tripolyphosphate polymeric nanoparticle as an NLRP3-dependent systemic adjuvant for the vaccine development.

Issue Release: 2024

What is Plasmodium falciparum Malaria?

What Are the Ethical Considerations?

How Do HDAC Inhibitors Work?

Where is Zika Virus Found?

What are Natural Killer (NK) Cells?

How is Inherited Immunity Studied?

What is Pathogenesis?

Can Symptomatic Relief Replace Primary Treatment?

How Does the Innate Immune System Interact with the Adaptive Immune System?

What are the Challenges in Implementing Genomic Technologies?

Cd4 Based Vaccines - Infectious Diseases

Relevant Publications

Partnered Content Networks

Relevant Topics